新云社 reports: Amundi Group Chief Investment Officer Vincent Mortier said investors have been “overly fixated” on core AI companies, and that this focus will shift by 2027. The European asset manager now favors sectors using AI to drive productivity gains and business transformation, including pharmaceuticals, biotech and some industrial firms. Mortier said the core AI segment is in the early stages of repricing, calling the adjustment “normal” after its extraordinary rally.
Amundi CIO says AI focus to shift by 2027, favors pharma and biotech
Share on WeChat
Open WeChat → Scan → then tap "…" to send to a chat or Moments.
Tap "…" in the top-right corner to send to a chat or share to Moments.
Related News
37m ago
Argentina approves LNG project under large-investment incentive scheme
45m ago
JackYi: Market Drop Tied to Global Financial Risk, Not Crypto Data
1h ago
Morgan Stanley Adds 799 BTC via MSBT, Total Holdings Reach 12,448 BTC
1h ago
US Stocks Slide: MSTR Down 12.4%, Nvidia Down 11.4%
1h ago
NDRC Holds Video Meeting on Government Investment Fund Disbursement and Project Reserves
1h ago
Iran says it shot down 58th US MQ-9 Reaper drone over Strait of Hormuz




